Effect of chronic delivery of the NOP/MOR partial agonist AT-201 and NOP antagonist J-113397 on heroin relapse in a rat model of opioid maintenance
The NOP/MOR partial agonist AT-201 and the NOP antagonist J-113397 did not mimic buprenorphine's inhibitory effects on relapse in a rat model of opioid maintenance treatment.
Authors
- Shelley N. Jackson (ORCID: https://orcid.org/0000-0002-3296-6913)
- Jennifer M. Bossert (ORCID: https://orcid.org/0000-0001-5636-4071)
- Ashley Batista
- Nurulain T. Zaveri (ORCID: https://orcid.org/0000-0002-6850-6732)
- Kiera E. Caldwell
- Agnieszka Sulima (ORCID: https://orcid.org/0000-0002-8849-9736)
- Yavin Shaham (ORCID: https://orcid.org/0000-0002-8242-3319)
- Hannah Korah
- Kenner C. Rice (ORCID: https://orcid.org/0000-0002-1147-9147)
- Ida Fredriksson (ORCID: https://orcid.org/0000-0002-3443-3870)
- Hannah Bonbrest
Institutions
- National Institutes of Health (US)
- Behavioral Pharma (United States) (US)
- National Institute on Aging (US)
- Astraea Therapeutics (United States) (US)
Publication Details
- Journal
- Psychopharmacology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1007/s00213-024-06678-7
- Citations
- 7
- Primary Topic
- Neuropeptides and Animal Physiology
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- National Institutes of Health
- National Institute on Drug Abuse